Virulence factors of the Mycobacterium tuberculosis complex

MA Forrellad, LI Klepp, A Gioffré, J Sabio y Garcia… - Virulence, 2013 - Taylor & Francis
The Mycobacterium tuberculosis complex (MTBC) consists of closely related species that
cause tuberculosis in both humans and animals. This illness, still today, remains to be one of …

Recent clinical experience with vaccines using MPL-and QS-21-containing adjuvant systems

N Garcon, M Van Mechelen - Expert review of vaccines, 2011 - Taylor & Francis
The immunostimulants 3-O-desacyl-4'-monophosphoryl lipid A (MPL) and the saponin QS-
21 are part of licensed or candidate vaccines. MPL and QS-21 directly affect the innate …

Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis

O Van Der Meeren, M Hatherill, V Nduba… - … England Journal of …, 2018 - Mass Medical Soc
Background A vaccine to interrupt the transmission of tuberculosis is needed. Methods We
conducted a randomized, double-blind, placebo-controlled, phase 2b trial of the M72/AS01E …

Bacterial flagellin is a dominant antigen in Crohn disease

MJ Lodes, Y Cong, CO Elson… - The Journal of …, 2004 - Am Soc Clin Investig
Chronic intestinal inflammation, as seen in inflammatory bowel disease (IBD), results from
an aberrant and poorly understood mucosal immune response to the microbiota of the …

[HTML][HTML] Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis

TJ Scriba, MG Netea, AM Ginsberg - Seminars in immunology, 2020 - Elsevier
Tuberculosis is the leading infectious disease killer globally due to a single pathogen.
Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine …

Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant …

YAW Skeiky, MR Alderson, PJ Ovendale… - The Journal of …, 2004 - journals.aai.org
Abstract Key Ags of Mycobacterium tuberculosis initially identified in the context of host
responses in healthy purified protein derivative-positive donors and infected C57BL/6 mice …

Novel vaccination strategies against tuberculosis

P Andersen, SHE Kaufmann - Cold Spring …, 2014 - perspectivesinmedicine.cshlp.org
The tuberculosis (TB) pandemic continues to rampage despite widespread use of the BCG
(Bacillus Calmette–Guérin) vaccine. Novel vaccination strategies are urgently needed to …

Advances in tuberculosis vaccine strategies

YAW Skeiky, JC Sadoff - Nature Reviews Microbiology, 2006 - nature.com
Tuberculosis (TB), an ancient human scourge, is a growing health problem in the
developing world. Approximately two million deaths each year are caused by TB, which is …

Comparative analysis of the Corynebacterium glutamicum group and complete genome sequence of strain R

H Yukawa, CA Omumasaba, H Nonaka… - …, 2007 - microbiologyresearch.org
The complete genome sequence of Corynebacterium glutamicum strain R was determined
to allow its comparative analysis with other corynebacteria. The biology of corynebacteria …

Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis …

I Leroux-Roels, S Forgus, F De Boever, F Clement… - Vaccine, 2013 - Elsevier
Abstract Background The Bacille Calmette–Guérin (BCG) tuberculosis (TB) vaccine provides
incomplete protection, necessitating development of an effective vaccine against TB …